Wed Jan 01 2025
CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
Drug | Manufacturer | Distribution Pattern | Number of Affected Units |
---|---|---|---|
Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA | Nationwide in the US | a) 1,564 cards, b) 799 bottles |